These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 8434467)

  • 1. Blood coagulation and its alterations in hemorrhagic and thrombotic disorders.
    Rapaport SI
    West J Med; 1993 Feb; 158(2):153-61. PubMed ID: 8434467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet coagulation-protein interactions.
    Walsh PN
    Semin Thromb Hemost; 2004 Aug; 30(4):461-71. PubMed ID: 15354267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
    Lämmle B; Griffin JH
    Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of tissue factor and its inhibitor in hemostasis].
    Naumnik B; Małyszko J; Myśliwiec M
    Przegl Lek; 1998; 55(2):68-73. PubMed ID: 9695646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulation Testing in the Core Laboratory.
    Winter WE; Flax SD; Harris NS
    Lab Med; 2017 Nov; 48(4):295-313. PubMed ID: 29126301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein Z: "light and shade" of a new thrombotic factor.
    Sofi F; Cesari F; Fedi S; Abbate R; Gensini GF
    Clin Lab; 2004; 50(11-12):647-52. PubMed ID: 15575306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extrinsic pathway inhibitor--the key to feedback control of blood coagulation initiated by tissue thromboplastin.
    Sandset PM; Abildgaard U
    Haemostasis; 1991; 21(4):219-39. PubMed ID: 1794748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current views of activating and regulatory mechanisms of blood coagulation].
    Osaki T; Ichinose A
    Nihon Rinsho; 2014 Jul; 72(7):1206-11. PubMed ID: 25163309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The extrinsic pathway inhibitor: a regulator of tissue factor-dependent blood coagulation.
    Rapaport SI
    Thromb Haemost; 1991 Jul; 66(1):6-15. PubMed ID: 1926052
    [No Abstract]   [Full Text] [Related]  

  • 10. Tissue factor as a tumor procoagulant.
    Rao LV
    Cancer Metastasis Rev; 1992 Nov; 11(3-4):249-66. PubMed ID: 1423817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lectin complement pathway serine proteases (MASPs) represent a possible crossroad between the coagulation and complement systems in thromboinflammation.
    Kozarcanin H; Lood C; Munthe-Fog L; Sandholm K; Hamad OA; Bengtsson AA; Skjoedt MO; Huber-Lang M; Garred P; Ekdahl KN; Nilsson B
    J Thromb Haemost; 2016 Mar; 14(3):531-45. PubMed ID: 26614707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
    Jespersen J
    Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology of Trousseau's syndrome.
    Dicke C; Langer F
    Hamostaseologie; 2015; 35(1):52-9. PubMed ID: 25403091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue factor pathway inhibitor and the revised theory of coagulation.
    Broze GJ
    Annu Rev Med; 1995; 46():103-12. PubMed ID: 7598447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor VII and haemostasis.
    Osterud B
    Blood Coagul Fibrinolysis; 1990 Jun; 1(2):175-81. PubMed ID: 2130929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the tissue factor coagulation pathway.
    Golino P; Forte L; De Rosa S
    Curr Vasc Pharmacol; 2004 Oct; 2(4):319-27. PubMed ID: 15320811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue factor in thrombosis and hemorrhage.
    Butenas S; Orfeo T; Brummel-Ziedins KE; Mann KG
    Surgery; 2007 Oct; 142(4 Suppl):S2-14. PubMed ID: 18019946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of current and emerging antithrombotics in thrombosis and cancer.
    Mousa SA
    Drugs Today (Barc); 2006 May; 42(5):331-50. PubMed ID: 16801996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coagulation factor and protease pathways in thrombosis and cardiovascular disease.
    Ten Cate H; Hackeng TM; García de Frutos P
    Thromb Haemost; 2017 Jun; 117(7):1265-1271. PubMed ID: 28594052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
    Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.